Pilones K, Aryankalayil J, Babb J, Demaria S. Invariant natural killer T cells regulate anti-tumor immunity by controlling the population of dendritic cells in tumor and draining lymph nodes. J Immunother Cancer. 2014;2:37 pubmed publisher

Hayworth J, Mazzuca D, Maleki Vareki S, Welch I, McCormick J, Haeryfar S. CD1d-independent activation of mouse and human iNKT cells by bacterial superantigens. Immunol Cell Biol. 2012;90:699-709 pubmed publisher

Yang W, Li H, Mayhew E, Mellon J, Chen P, Niederkorn J. NKT cell exacerbation of liver metastases arising from melanomas transplanted into either the eyes or spleens of mice. Invest Ophthalmol Vis Sci. 2011;52:3094-102 pubmed publisher

Miellot Gafsou A, Biton J, Bourgeois E, Herbelin A, Boissier M, Bessis N. Early activation of invariant natural killer T cells in a rheumatoid arthritis model and application to disease treatment. Immunology. 2010;130:296-306 pubmed publisher

Shi M, Wang C, Wei G, Pan W, Appleyard G, Tabel H. Experimental African trypanosomiasis: lack of effective CD1d-restricted antigen presentation. Parasite Immunol. 2006;28:643-7 pubmed

D Souza C, Cooper A, Frank A, Ehlers S, Turner J, Bendelac A, et al. A novel nonclassic beta2-microglobulin-restricted mechanism influencing early lymphocyte accumulation and subsequent resistance to tuberculosis in the lung. Am J Respir Cell Mol Biol. 2000;23:188-93 pubmed

Szalay G, Ladel C, Blum C, Brossay L, Kronenberg M, Kaufmann S. Cutting edge: anti-CD1 monoclonal antibody treatment reverses the production patterns of TGF-beta 2 and Th1 cytokines and ameliorates listeriosis in mice. J Immunol. 1999;162:6955-8 pubmed